CJC-1295 w/o DAC 10mg Peptides
Clarity in research begins with uncompromising materials you can trust.
Better Molecule CJC-1295 w/o DAC is a lyophilized peptide vial designed for precise laboratory work, providing a clean, reliable foundation for growth hormone–axis investigations. This single-vial format contains a total of 10mg and is prepared to support exacting protocols that require consistency, reproducibility, and traceable quality.
- Each vial contains 10mg of CJC-1295 w/o DAC, a growth hormone–releasing hormone analog widely studied for its role in modulating pulsatile GH signaling in research models, enabling controlled evaluations of receptor activity, timing, and pathway dynamics.
Engineered as a stable lyophilized powder, this peptide is suited for reconstitution according to laboratory requirements, enabling measured aliquoting and protocol-specific concentrations. The solid-state cake is handled to minimize variability, supporting uniform dissolution and clear preparation when used with appropriate laboratory-grade diluents. The format is optimized for researchers who prioritize repeatable execution and clean documentation from lot to lot.
Every vial reflects Better Molecule’s disciplined approach to quality. Lots are produced and handled under strict procedures, featuring analytical verification for identity and purity (HPLC/LC-MS) and lot-level traceability to support audit-friendly recordkeeping. Packaging is designed to protect integrity from receipt to storage, with careful attention to temperature control, moisture protection, and tamper-evident measures during fulfillment. As a USA-based supplier, we emphasize responsible sourcing, controlled handling, and transparent documentation so researchers can focus on data, not doubt.
Trust, transparency, and consistency guide our standards: precise specifications, clear labeling, and access to documentation provide confidence at setup and throughout the study. For best results, follow your institution’s SOPs for reconstitution, handling, and storage, and consult lot documentation for testing details relevant to your protocol.
For laboratory research use only. Not for human consumption, medical, veterinary, or household use. This product is supplied solely for qualified research professionals operating under appropriate protocols and safety standards.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Better Molecule are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
